NEWS

Latest in Stem Cell Research

  • Keck Medical Center of USC today announced that a team of doctors became the first in California to inject an experimental treatment made from stem cells, AST-OPC1, into the damaged cervical spine of a recently paralyzed 21-year-old man as part of a multi-center clinical trial. On March 6, just shy of his 21st birthday, Kristopher […]

    Read more
  • Scientists from Rutgers and Stanford universities have developed a potentially revolutionary technique to grow new neurons from adult stem cells and better ensure their survival during transplantation to the brain. The method, involving the use of 3-D scaffolds, may one day help to treat amyotrophic lateral sclerosis (ALS). Published in the journal Nature Communications, the study involved a large […]

    Read more
  • A single injection of stem cells could one day restore normal bone structure in patients with osteoporosis, say researchers who achieved this reversal in mice. The findings are published in Stem Cells Translational Medicine. lobally, over 200 million people are living with either postmenopausal osteoporosis, which is known as type 1 osteoporosis and affects women […]

    Read more
  • Researchers have taken a huge step towards regrowing organs by successfully creating functional heart tissue out of adult stem cells. The breakthrough could mean that repairs to damaged hearts could be performed with a patient’s own cells. That reduces the need to find a matching doner and also reduces chances that the body will reject […]

    Read more
  • The safety trial, led by the Murdoch Childrens Research Institute, will recruit patients nationally and take place at The Royal Children’s Hospital. Expected to take two years, the study is being funded by the Cerebral Palsy Alliance Research Foundation and Cell Care, Australia’s largest private cord blood bank. It is the first step in a […]

    Read more
  • More than half of all cases of blindness are caused by cataracts – the clouding of the eye’s lens. An implanted lens is normally needed to restore sight, but the operation described in Nature activated stem cells in the eye to grow a new one. Experts describe the breakthrough as one of the finest achievements […]

    Read more
  • The Wisconsin Alumni Research Foundation recently secured a provisional patent to protect a new strategy to increase the number of blood stem cells. According to a new study published early online in Stem Cell Reports, Emery Bresnick, a professor of cell and regenerative biology and the director of the UW-Madison Blood Research Program at the […]

    Read more
  • Doctors in Spain have announced the world’s first clinical trial to cure five HIV patients within three years using transplants of blood from umbilical cords. Spain’s National Organization of Transplants (ONT) announced a plan that will be the world’s first of its kind to cure five people with HIV over the next three years, recreating […]

    Read more
  • An umbilical cord blood donation from one Quebec brother to another has made Canadian history as the first stem-cell transplant among siblings from a public umbilical cord bank. Nolan Laberge, left, was cured of a rare blood cancer thanks to an umbilical cord donation from older brother Nathis, right, made years earlier to a public […]

    Read more
  • Autism Spectrum Disorder (ASD) may be associated with an overproduction of inhibitory neurons, according to a new study. ASD is a group of complex neurodevelopmental disorders characterized by communication problems, social deficits, and repetitive behaviors. Some studies have revealed a link between certain genes and ASD, but the majority of cases are idiosyncratic, meaning their […]

    Read more
  • Canadian researchers have published promising results of the first clinical trial in the world of a genetically-enhanced stem cell therapy for pulmonary arterial hypertension (PAH). This rare and deadly disease mainly affects young women, and is characterized by very high pressure in the arteries supplying blood to the lungs. In some cases, PAH is caused […]

    Read more
  • By targeting inflammation, adult allogeneic bone-marrow–derived mesenchymal precursor cells (MPCs) may represent a novel treatment for type 2 diabetes, a new pilot study suggests. Findings from the multicenter dose-escalating randomized placebo-controlled trial in 61 adults with inadequately controlled type 2 diabetes were published in Diabetes Care by Jay S Skyler, MD, deputy director for clinical […]

    Read more
1 2 3 4 5 6